Immunohistochemical localization of the neural cannabinoid receptor in rat brain

Journal of Neuroscience Research

Volumn 51, Issue 3, 1998, Pages 391-402

  Dove Pettit, Denise A ^a   Harrison, Matthew P ^a   Olson, John M ^a   Spencer, Robert F ^a   Cabral, Guy A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cannabinoid receptor; Cannabinoid receptor distribution; CB1; Immunohistochemistry; THC

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ANTISERUM; CANNABINOID RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; POLYCLONAL ANTIBODY; TETRAHYDROCANNABINOL;

ANIMAL TISSUE; ARTICLE; BRAIN; CENTRAL NERVOUS SYSTEM; DRUG RECEPTOR BINDING; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE DISTRIBUTION;

ANIMALS; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; BRAIN CHEMISTRY; CANNABINOIDS; IMMUNOHISTOCHEMISTRY; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; STAINING AND LABELING;

EID: 2642703409     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19980201)51:3<391::AID-JNR12>3.0.CO;2-A     Document Type: Article

References (34)

1. Bidaut-Russell M, Devant: WA, Hewlett AC (1990): Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain. J Neurochem 55:21-26.
2. Devane WA, Dysarz FA III, Johnson MR, Melvin LS, Howlett AC (1988): Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605-613.
3. Devereux J, Haeberli P, Smithies O (1984): A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res 12:387-395.
4. Dewey WL (1986): Cannabinoid pharmacology. Pharmacol Rev 38:51-178.
5. Felder CC, Veluz JS, Williams HL, Briley EM, Matsuda LA (1992): Cannabinoid agonists stimulate both receptor and non-receptor-mediated signal transduction pathways in cells transfected with and expressing Cannabinoid receptor clones. Mol Pharmacol 42:838-845.
6. Felder CC, Nielsen A, Briley EM, Palkovits M, Priller J, Axelrod J, Nguyen DN, Richardson JM, Riggin RM, Koppel A (1996): Isolation and measurement of the endogenous Cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett 393:231-235.
7. Garzon J, Juarros JL, Castro MA, Sanchez-Blazquez P (1995): Antibodies to the cloned μ-opioid receptor detect various molecular weight forms in areas of mouse brain. Mol Pharmacol 47:738-744.
8. Hanker JS, Yates PE, Metz CB, Rustioni A (1977): A new specific, sensitive and non-carcinogenic reagent for the demonstration of horseradish peroxidase. Histochem J 9:789-792.
9. Herkenham M, Lynn AB, Little MD, Ross Johnson MR, Melvin LS, de Costa BR, Rice KC (1990): Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87:1932-1936.
10. Herkenham M, Groen BGS, Lynn AB, De Costa BR, Richfield EK (1991a): Neuronal localization of Cannabinoid receptors and second messengers in mutant mouse cerebellum. Brain Res 552:301-310.
11. Herkenham M, Lynn AB, Ross Johnson MR, Melvin LS, de Costa BR, Rice KC (1991b): Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J Neuroscience 11:563-583.
12. Hillard CJ, Harris RA, Bloom AS (1985): Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: Fluorescence studies. J Pharmacol Exp Ther 232:579-588.
13. Hollister LE (1986): Health aspects of cannabis. Pharmacol Rev 38:1-20.
14. Howlett AC (1985): Cannabinoid inhibition of adenylate cyclase: Biochemistry of the response in neuroblastoma cell membranes. Mol Pharmacol 27:429-136.
15. Howlett AC (1987): Cannabinoid inhibition of adenylate cyclase: Relative activity of constituents and metabolites of marihuana. Neuropharmacology 26:507-512.
16. Howlett AC, Fleming RM (1984): Cannabinoid inhibition of adenylate cyclase: Pharmacology of the response in neuroblastoma cell membranes. Mol Pharmacol 26:532-538.
17. Kaminski NE, Abood ME, Kessler FK, Martin BR, Schatz AR (1992): Identification of a functionally relevant Cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol Pharmacol 42:736-742.
18. Laemmli UK (1970): Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
19. Little PJ, Compton DR, Johnson MR, Melvin LS, Martin BR (1988): Pharmacology and stereoselectivity of structurally novel cannabinoids in mice. J Pharmacol Exp Ther 247:1046-1051.
20. Mailleux P, Vanderhaeghen JJ (1992): Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48:655-668.
21. Martin BR (1986): Cellular effects of cannabinoids. Pharmacol Rev 38:45-74.
22. Martin BR, Balster RL, Razdan RK, Harris LS, Dewey WL (1981): Behavioral comparisons of the stereoisomers of tetrahydrocannabinols. Life Sci 29:565-574.
23. Matsuda LA, Lolait SJ, Brownstein MJ, Young AJ, Bonner TI (1990): Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564.
24. Matsuda LA, Bonner TI, Lolait SJ (1993): Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol 327:535-550.
25. Munson AE, Fehr KO (1983): Immunological effects of cannabis. In Fehr KO and Kalant H (eds): Cannabis and Health Hazards. Toronto: Alcoholism and Drug Addiction Research Foundation, pp 257-353.
26. Munro S, Thomas KL, Abu-Shaar M (1993): Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61-65.
27. Pettit DAD, Showalter VM, Abood ME, Cabrai GA (1994): Expression of a cannabinoid receptor in baculovirus-infected insect cells. Biochem Pharmacol 48:1231-1243.
28. Pettit DAD, Anders DL, Harrison MP, Cabrai GA (1996): Cannabinoid receptor expression in immune cells. In Friedman H, Eisenstein TK, Madden J, Sharp BM (eds): "AIDS, Drugs of Abuse, and the Neuroimmune Axis." New York: Plenum Press, pp 119-129.
29. Shire D, Carillon C, Kaghad M, Calandra B, Rinaldi-Carmona M, Le Fur G, Caput D, Ferrara P (1995): An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J Bio Chem 270:3726-3731.
30. Shire D, Carillon C, Kaghad M, Calandra B, Rinaldi-Carmona M, Le Fur G, Caput D, Ferrara P (1997): Retraction of the finding that CB1A is present in rat tissue. J Bio Chem 271:33706.
31. Skaper SD, Buriani A, Toso RD, Petrelli L, Romanello S, Facci L, Lion A (1996): The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc Natl Acad Sci USA 93:3984-3989.
32. 35S]thiol-triphosphate binding. Proc Natl Acad Sci USA 92:7242-7246.
33. 9-THC-DMH. J Pharmac Exp Ther 263: 1383-1390.
34. Turner CE (1984): Marijuana and cannabis: Research. Why the conflict. In Harvey DJ (ed): "Marihuana '84." Oxford: IRL Press, pp 31-36.